XML 81 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities:      
Net income $ 31,085 $ 28,965 $ 22,669
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 12,090 10,837 9,346
Loss on retirement of fixed assets 23 6 2
Amortization of deferred financing costs and accreted interest 541 303 480
Loss on extinguishment of debt     422
Share based compensation 8,209 6,918 6,974
Excess tax benefit on stock options (6,775) (1,514) (1,354)
Deferred income taxes 4,970 2,746 1,634
Provision for doubtful accounts 97 38 46
Unrealized currency (gain) loss on foreign denominated intercompany transactions (216) (390) 94
Unrealized loss (gain) on derivatives   681 136
Changes in operating assets and liabilities, net of effect of acquisitions:      
Accounts receivable (1,437) 129 (1,835)
Prepaid expenses and other assets (899) 488 117
Accounts payable 60 (113) 366
Accrued income taxes payable 3,312 (635) (86)
Accrued expenses and other liabilities 1,820 900 1,275
Deferred revenue (1,544) 1,069 (973)
Net cash provided by operating activities 51,336 50,428 39,313
Cash flows from investing activities:      
Purchases of property and equipment (2,124) (1,486) (1,925)
Purchase of exclusive license and other intangible assets   (150)  
Acquisition of businesses, net of cash acquired (72) (51,525) (219)
Net cash used in investing activities (2,196) (53,161) (2,144)
Cash flows from financing activities:      
Payments on long-term debt (22,321) (40,000) (86,845)
Proceeds from issuance of debt, net of issuance costs   25,000 56,065
Excess tax benefit of stock options 6,775 1,514 1,354
Common stock dividend paid (8,456) (1,482)  
Purchase of treasury stock (2,193)    
Proceeds from exercise of common stock options 16,109 3,215 3,330
Net cash used in financing activities (10,086) (11,753) (26,096)
Effect of exchange rates on cash and cash equivalents 17 (24) (9)
Increase (decrease) in cash and cash equivalents 39,071 (14,510) 11,064
Cash and cash equivalents, beginning of year 39,340 53,850 42,786
Cash and cash equivalents, end of year 78,411 39,340 53,850
Supplemental disclosures:      
Interest paid 599 1,416 2,279
Income taxes paid 8,456 11,518 9,070
Non cash transactions:      
Dividends declared 2,357 1,492  
Excess tax benefit on stock options   $ 413